Correction to: Clinical characterization, genetic profiling, and immune infiltration of TOX in diffuse gliomas
Hao Zhang(Northwestern Polytechnical University), Quan Cheng(Central South University), Fangkun Liu(Central South University), Ziyu Dai(Central South University), Zeyu Wang(Anhui University), Liyang Zhang(Central South University), Zhixiong Liu(Central South University), Yuanqiang Yu(Central South University)
Cited by 4
Related Papers
Glioma targeted therapy: insight into future of molecular approaches
|Molecular Cancer|2022|727
CGCG clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2016|650
PARP inhibitor resistance: the underlying mechanisms and clinical implications
|Molecular Cancer|2020|548
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
|Journal of Experimental & Clinical Cancer Research|2021|535
Clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2020|482